Fexmid is a Oral Tablet, Film Coated in the Human Prescription Drug category. It is labeled and distributed by Proficient Rx Lp. The primary component is Cyclobenzaprine Hydrochloride.
| Product ID | 71205-059_1e285841-228e-4bd6-931a-6ead64ba018c |
| NDC | 71205-059 |
| Product Type | Human Prescription Drug |
| Proprietary Name | Fexmid |
| Generic Name | Cyclobenzaprine Hydrochloride |
| Dosage Form | Tablet, Film Coated |
| Route of Administration | ORAL |
| Marketing Start Date | 2018-04-30 |
| Marketing Category | ANDA / ANDA |
| Application Number | ANDA071611 |
| Labeler Name | Proficient Rx LP |
| Substance Name | CYCLOBENZAPRINE HYDROCHLORIDE |
| Active Ingredient Strength | 8 mg/1 |
| Pharm Classes | Centrally-mediated Muscle Relaxation [PE], Muscle Relaxant [EPC] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2023-12-31 |
| Marketing Start Date | 2022-01-05 |
| NDC Exclude Flag | N |
| Sample Package? | N |
| Marketing Category | ANDA |
| Application Number | ANDA071611 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | EA |
| Marketing Start Date | 2018-06-01 |
| Marketing Category | ANDA |
| Application Number | ANDA071611 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | EA |
| Marketing Start Date | 2018-06-01 |
| Marketing Category | ANDA |
| Application Number | ANDA071611 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | EA |
| Marketing Start Date | 2018-06-01 |
| Marketing Category | ANDA |
| Application Number | ANDA071611 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | EA |
| Marketing Start Date | 2018-06-01 |
| Marketing Category | ANDA |
| Application Number | ANDA071611 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | EA |
| Marketing Start Date | 2019-03-01 |
| Ingredient | Strength |
|---|---|
| CYCLOBENZAPRINE HYDROCHLORIDE | 7.5 mg/1 |
| SPL SET ID: | 2ca861a8-bbb2-4abb-95ba-054cfe825b5a |
| Manufacturer | |
| UNII | |
| RxNorm Concept Unique ID - RxCUI |
| NDC | Brand Name | Generic Name |
|---|---|---|
| 70199-014 | Fexmid | Fexmid |
| 71205-059 | Fexmid | Fexmid |
| 21695-830 | Fexmid | Fexmid |
| 50436-0950 | Fexmid | Fexmid |
| 53149-4851 | Fexmid | Fexmid |
| 53149-4850 | Fexmid | Fexmid |
| 55700-726 | Fexmid | Fexmid |
| 63629-7803 | Fexmid | Fexmid |
| 71335-1253 | Fexmid | Fexmid |
| 0093-1920 | Cyclobenzaprine Hydrochloride | Cyclobenzaprine Hydrochloride |
| 0093-1921 | Cyclobenzaprine Hydrochloride | Cyclobenzaprine Hydrochloride |
| 0093-3420 | Cyclobenzaprine Hydrochloride | Cyclobenzaprine Hydrochloride |
| 0093-3421 | Cyclobenzaprine Hydrochloride | Cyclobenzaprine Hydrochloride |
| 0093-3422 | Cyclobenzaprine Hydrochloride | Cyclobenzaprine Hydrochloride |
| 0115-1436 | Cyclobenzaprine Hydrochloride | Cyclobenzaprine Hydrochloride |
| 0115-1437 | Cyclobenzaprine Hydrochloride | Cyclobenzaprine Hydrochloride |
| 0179-0057 | cyclobenzaprine hydrochloride | cyclobenzaprine hydrochloride |
| 0179-0189 | cyclobenzaprine hydrochloride | cyclobenzaprine hydrochloride |
| 0378-0751 | Cyclobenzaprine Hydrochloride | cyclobenzaprine hydrochloride |
| 0378-0761 | Cyclobenzaprine Hydrochloride | cyclobenzaprine hydrochloride |
| 0378-0771 | Cyclobenzaprine Hydrochloride | cyclobenzaprine hydrochloride |
| 0440-1350 | Cyclobenzaprine Hydrochloride | Cyclobenzaprine Hydrochloride |
| 0440-7350 | Cyclobenzaprine Hydrochloride | Cyclobenzaprine Hydrochloride |
| 0591-3256 | Cyclobenzaprine Hydrochloride | Cyclobenzaprine Hydrochloride |
| 0591-3330 | Cyclobenzaprine Hydrochloride | Cyclobenzaprine Hydrochloride |
| 0591-5658 | Cyclobenzaprine Hydrochloride | Cyclobenzaprine Hydrochloride |
| 0615-3520 | Cyclobenzaprine Hydrochloride | cyclobenzaprine hydrochloride |
| 0615-7528 | Cyclobenzaprine Hydrochloride | cyclobenzaprine hydrochloride |
| 0615-8182 | Cyclobenzaprine Hydrochloride | Cyclobenzaprine Hydrochloride |
| 0904-7809 | Cyclobenzaprine Hydrochloride | Cyclobenzaprine Hydrochloride |
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
![]() FEXMID 78957905 3327963 Live/Registered |
CASPER PHARMA LLC 2006-08-22 |